Given that our data suggest that loss of c-FLIPL can promote luminal filling in mammary acini, we reasoned that elevation of c-FLIPL levels in invasive breast cancer cells may compromise their capacity to thrive in an anchorage-independent setting. This evidence concerns the gene CFLAR and invasive breast carcinoma.